YOLFTbeta
00

Yuyu Pharma

000220 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

3,795.00KRW-5.00 (-0.13%)

Price History

Full chart

Market Stats

Previous Close3,800.00
Open3,810.00
Day Range3,750.00 – 3,830.00
52-Week Range3,320.00 – 4,971.66
Volume40.91K
Market Cap58.66B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.11%
Beta0.41
50-Day Avg3,747.00
200-Day Avg4,085.08

About

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wonsang Yu
  • Employees243
  • Headquarters94 Biovalley 1-ro, Jecheon-si, South Korea, 27159, Korea
  • Websitehttps://www.yuyu.co.kr

Leadership

  • Mr. Wonsang YuCEO & Director · b. 1974
  • NoYong ParkCEO & Inside Director

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue58.80B61.98B61.99B62.82B69.74B71.58B62.85B83.10B90.88B98.12B115.66B138.88B137.21B133.15B140.88B
Growth (%)-+5.42%+0.02%+1.33%+11.03%+2.63%-12.19%+32.21%+9.36%+7.97%+17.87%+20.08%-1.20%-2.96%+5.81%
Cost of Revenue24.42B25.58B28.40B30.58B38.96B38.21B32.87B42.46B44.27B52.85B70.32B85.57B88.31B81.44B86.94B
Gross Profit--32.29B31.01B30.78B33.37B29.99B40.64B46.61B45.27B45.34B53.31B48.90B51.70B53.94B
Gross Margin--52.08%49.36%44.13%46.62%47.71%48.90%51.29%46.14%39.20%38.39%35.64%38.83%38.29%
Operating Expense--30.53B29.64B29.17B29.64B26.42B35.31B38.54B39.00B44.14B53.91B48.53B39.12B42.92B
Operating Income2.16B3.72B1.76B1.37B1.61B3.73B3.57B5.33B8.07B6.27B1.20B-592.11M364.54M12.58B11.02B
Operating Margin3.67%6.00%2.83%2.18%2.31%5.22%5.68%6.41%8.89%6.39%1.04%-0.43%0.27%9.45%7.82%
EBITDA------6.66B7.90B11.51B9.37B6.30B3.80B2.72B18.87B17.57B
EBITDA Margin------10.59%9.50%12.66%9.55%5.44%2.73%1.98%14.17%12.47%
Net Income1.48B2.76B1.63B-7.47B-252.68M5.89B4.54B4.02B4.72B1.28B-2.21B-5.99B-7.18B8.72B8.15B
Net Income Margin2.51%4.45%2.63%-11.89%-0.36%8.22%7.23%4.84%5.20%1.31%-1.91%-4.31%-5.23%6.55%5.79%
R&D-1.24B999.22M1.13B1.25B2.25B1.69B1.42B876.67M4.12B4.01B8.62B7.19B2.78B3.61B
R&D as % of Total Revenue-2.01%1.61%1.80%1.79%3.14%2.69%1.71%0.96%4.20%3.47%6.21%5.24%2.09%2.56%
Interest Expense00000001.12B1.79B1.76B2.18B2.58B2.55B3.22B2.48B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.35%1.97%1.79%1.88%1.86%1.86%2.42%1.76%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets88.51B88.68B96.26B101.40B104.33B111.30B121.49B135.23B137.72B154.90B192.99B195.21B198.21B207.69B207.22B
Total Liabilities21.28B19.18B23.99B29.91B30.60B33.01B38.66B48.35B47.17B37.86B64.30B71.83B77.86B72.62B66.68B
Total Equity67.27B69.42B71.37B70.42B71.56B77.16B81.96B85.79B88.69B114.36B124.28B116.82B112.19B125.23B129.63B
Cash3.30B2.61B7.37B11.12B9.83B18.91B19.81B26.97B26.85B20.32B50.26B25.84B30.60B41.83B29.09B
Net Debt-------244.28M---12.64B7.97B--

Cash Flow

Currency: KRW2006-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.67B6.51B-775.17M1.36B-11.68B9.82B561.35M6.11B13.19B-2.67B4.51B-6.23B420.86M24.95B15.88B
Investing Cash Flow----2.75B2.87B-3.53B1.45B-3.43B-9.94B-5.33B-12.14B-5.89B-8.54B---
Financing Cash Flow---8.29B-495.71M13.94B-2.20B1.78B10.95B-8.04B8.51B31.31B-9.08B---
Capital Expenditure0408.49M805.15M954.78M404.37M2.09B2.32B5.19B9.76B8.06B12.05B6.07B5.28B5.11B7.30B8.45B
Free Cash Flow--------3.20B-3.96B4.45B-16.96B-2.24B-11.80B-4.69B17.65B7.42B
Dividends Paid-600.46M717.96M952.96M1.07B1.20B1.27B1.27B1.38B1.44B1.52B1.85B2.03B2.00B-1.93B
FCF to OCF--------569.80%-64.81%33.74%635.38%-49.73%189.38%-1113.29%70.73%46.75%
Dividend Paid to FCF--------39.83%-34.95%32.45%-8.96%-82.56%-17.24%-42.72%-25.99%

Earnings

Report DateJun 29, 2006Aug 13, 2007Nov 14, 2007Sep 2, 2009Dec 2, 2009Mar 3, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 12, 2012Nov 14, 2012Feb 14, 2013Jun 29, 2013Aug 14, 2013Nov 14, 2013Feb 14, 2014Jun 14, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016May 31, 2017Aug 30, 2017Nov 29, 2017Feb 28, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Feb 14, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 30, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Feb 23, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Mar 2, 2022Apr 4, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023May 31, 2023Aug 30, 2023Nov 29, 2023Feb 28, 2024Apr 1, 2024Aug 28, 2024Nov 27, 2024Feb 26, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate213.00355.00289.50----------------------------------------------------------------
EPS Actual216.90500.00164.00-352.11-114.68135.8123.01-216.18174.91120.7534.8874.5968.16-12.9512.67-3.0523.74234.4210.0327.5822.1399.94-115.7465.9369.43-592.44-53.14-25.0440.2216.80106.95108.90127.7084.90127.9468.0634.1466.6598.7584.2480.25108.55162.92-97.7052.89-38.0927.33-14.47-40.66-109.18-21.88-88.31-129.53-138.561.52-218.16-171.97-55.54319.8866.58187.70-294.83155.4412.63185.0067.41186.54
Surprise1.83%40.85%-43.35%----------------------------------------------------------------
TimingPre-marketAfter-hoursPre-market-----------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market---------------------

Key Statistics & Ratios

Market Cap58.66B
Enterprise Value60.97B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.41
Price / Book0.44
Revenue (TTM)144.37B
Gross Profit (TTM)55.69B
EBITDA18.81B
Profit Margin8.66%
Operating Margin10.91%
Return on Equity8.85%
Return on Assets4.02%
Shares Outstanding15.75M
Shares Float10.09M
Beta0.41
Dividend Yield3.11%
Dividend Rate115.00
Payout Ratio26.20%

Dividends

20251×
115.00Dec 29, 2025
20241×
100.00Dec 27, 2024
20221×
105.00Dec 28, 2022
20211×
105.00Dec 29, 2021
20201×
105.00Dec 29, 2020
20191×
105.00Dec 27, 2019
20181×
100.00Dec 27, 2018
20172×
95.00Dec 27, 201790.00Mar 30, 2017
20161×
90.00Mar 30, 2016
20151×
90.00Mar 30, 2015
20141×
90.00Mar 28, 2014
20131×
80.00Mar 28, 2013
20121×
60.00Mar 29, 2012
20111×
50.00Mar 30, 2011
20101×
33.84Mar 30, 2010
20091×
35.00Mar 30, 2009
20081×
150.00Mar 28, 2008
20071×
120.00Mar 29, 2007
20061×
110.00Mar 30, 2006
20051×
105.00Mar 30, 2005
20041×
100.00Mar 30, 2004
20031×
90.00Mar 28, 2003
20021×
80.00Mar 28, 2002

Stock Splits

  • Mar 30, 20212:1
  • Feb 6, 20065:1
  • Mar 29, 20011.06:1
  • Mar 30, 20001.08:1